All In Biotech

Drug Trial Radar · NCT07739368

Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial With Ferric Maltol Capsules for the Treatment of Iron Deficiency Anemia in Subjects With Inflammatory Bowel Disease and Refractory/Intolerant to Oral Ferrous Preparations

Last checked: Nov 20, 2026Latest source record: Jul 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 122 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

122

Actual

Start

Sep 1, 2021

Primary completion

Feb 20, 2025

Study completion Mar 20, 2025

Sponsor

Sponsor type
Industry
First posted
Jul 31, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether Ferric Maltol, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with inflammatory bowel disease (IBD).

Conditions

  • Iron Deficiency Anaemia

Interventions

  • Ferric MaltolDrug

    30 mg capsules to be taken orally twice a day for 12 weeks

  • Placebo Oral CapsuleDrug

    Matching placebo capsules for Ferric Maltol to be taken orally twice a day for 12 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Haemoglobin (Hb) Concentration From Baseline to Week 12Time frame: Baseline to Week 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Jiangsu Aosaikang Pharm

    Nanjing, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.